Expansion, differentiation, and validation of neural progenitor cells (NPCS) from human induced pluripotent stem cells (IPSCS)
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95020C00034
- Awardee
-
New York Stem Cell Foundation Inc. UEI ZCKCL8KFL3B9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $414,000
Award facts
- Opportunity
-
- Expansion, Differentiation, and Validation of Neural Progenitor Cells (NPCs) from Human Induced Pluripotent Stem Cells (iPSCs) Derived from Psychiatrically Revelent Subjects. Pre-Solicitation · NIMH20203939 · Posted Jun 3, 2020
- Expansion, Differentiation, and Validation of Neural Progenitor Cells (NPCs) from Human Induced Pluripotent Stem Cells (iPSCs) Derived from Psychiatrically Revelent Subjects. Award Notice · Posted Sep 28, 2020
- Contract value 100% obligated
- $414,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10019, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $414,000 |
About this award
The National Institute of Drug Abuse awarded a $414,000 firm fixed price definitive contract to New York Stem Cell Foundation Inc. to provide expansion, differentiation, and validation of 36 neural progenitor cell lines derived from induced pluripotent stem cells obtained from subjects with psychiatric conditions. The original solicitation sought proposals to outsource these services within specified timeframes, with an emphasis on technical approach. New York Stem Cell Foundation will complete induced pluripotent stem cell expansion within seven months of the September 2020 start date, ship cell cultures and quality control reports within 21 days of reporting results, and retain detailed records for two years at the National Institute of Mental Health or National Institute on Drug Abuse. There is no set-aside designation for this contract to advance the National Institute on Drug Abuse's understanding of psychiatrically relevant conditions through stem cell research.
Quick answers
Who was awarded contract 75N95020C00034?
75N95020C00034 was awarded to New York Stem Cell Foundation Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2020.
How much is contract 75N95020C00034 worth?
The government has obligated $414,000 on 75N95020C00034.
Was contract 75N95020C00034 competed?
The extent of competition for 75N95020C00034 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award